.
Nipple discharge
Jaundice
Edema or peau d'orange
Dilated leg veins
MRI
Ultrasonography
Scintimammography
PET-CT scanning
Women with ductal carcinoma in situ (DCIS) planning on breast-conserving surgery
Women with DCIS who will be undergoing mastectomy
Women who previously underwent breast and/or axillary surgery
Women who received preoperative/neoadjuvant systemic therapy
Chemotherapy
Endocrine therapy
Combination chemotherapy and endocrine therapy
None of the above
Single-agent regimens are the standard of care
Taxanes are cardiotoxic, which makes substitution of one taxane for another difficult
Combinations of cytotoxic agents may be preferable in patients with life-threatening disease and/or severe symptoms
Any targeted agents other than hormone therapy should be only administered as monotherapy